Development of Lung Vibration Equipment

Launched by BURAPHA UNIVERSITY · Jun 30, 2025

Keywords

ClinConnect Summary

This clinical trial is testing a new portable device designed to gently vibrate the lungs, helping to loosen and clear mucus that can build up and cause breathing problems. The device is easy to use and can run on batteries or be recharged, making it convenient for patients. The goal is to improve mucus drainage, prevent complications, and potentially shorten hospital stays and reduce treatment costs.

If you are between 18 and 59 years old and currently staying in Burapha University Hospital with mucus buildup in your lungs, you might be eligible to join this study, especially if your doctor has recommended physical therapy to help clear your lungs. However, certain conditions like chest wounds, unstable heart or breathing rates, bleeding risks, or specific lung infections mean you wouldn’t qualify. Participants will use the lung vibration device as part of their care, and the research team will monitor how well it helps improve lung health. This study is still recruiting patients who meet these criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female
• • Aged 18-59 years
• • Inpatients at Burapha University Hospital, Mueang District, Chonburi Province, with pulmonary secretion retention
• • Referred by their attending physician for enhanced secretion clearance through physical therapy methods
• Exclusion Criteria:
• • Having inflamed wounds on the chest or back
• • Having unstable vital signs, defined as: resting heart rate \<60 or \>100 beats per minute; blood pressure \<90/60 or \>120/80 mmHg; respiratory rate \<12 or \>20 breaths per minute; oxygen saturation \<95%; and body temperature \>37°C
• • Having a bleeding tendency, defined as a platelet count \<20,000 per cubic millimeter
• • Taking medications that increase bleeding risk within 7 days prior to participation, including: Anticoagulants (such as Warfarin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban), Antiplatelet agents (such as Aspirin, Clopidogrel, Dipyridamole, Prasugrel, Ticagrelor)
• • Having an International Normalized Ratio (INR) \>1.1 for those not on anticoagulants, and \>3.0 for those on anticoagulants
• • Having subcutaneous emphysema
• • Experiencing severe hemoptysis (coughing up blood)
• • Having chest wall pain
• • Having acute spinal cord injury, rib fractures, or conditions associated with high fracture risk
• • Having skin grafts or burn wounds
• • Being admitted to intensive care units (ICU, RICU, or CICU)
• • Having untreated pneumothorax
• • Having an acute inflammatory process of the respiratory system
• • Having inflammatory or infectious conditions such as tuberculosis, lung abscess, or COVID-19
• • Having respiratory diseases that are contraindications or precautions for lung vibration, including COPD, uncomplicated pneumonia, asthma, lung cancer, or metastatic cancer